Next Quarterly Earnings
Monday, November 9, 2026
Expected
KalVista Pharmaceuticals
KalVista Pharmaceuticals is a US-based biotechnology company specializing in the development of innovative small-molecule drugs. The company focuses on treating hereditary angioedema (HAE) by researching advanced plasma kallikrein inhibitors to provide effective therapeutic solutions for patients worldwide.
Frequently asked questions
How often has KalVista Pharmaceuticals beaten expectations?
KalVista Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 4 evaluated quarters (beat rate: 50%).
How do I add the KalVista Pharmaceuticals earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
In the earnings calendar
Earnings statistics
Estimates vs. results
2/4
Quarters above estimates
50%
Beat rate
+0.7%
Avg. EPS surprise
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
KalVista Pharmaceuticals
Country
🇺🇸
More Financial Information